Bide Pharmatech (688073.SH) has repurchased a total of 1.6162 million shares with a total investment of 70.4314 million yuan.
Bide Pharmaceutical (688073.SH) announced that as of February 29, 2024, the company has passed the Shanghai Securities...
Bide Pharmatech (688073.SH) announced that as of February 29, 2024, the company has repurchased a total of 1.6162 million shares through the Shanghai Stock Exchange trading system by means of centralized bidding trading. This represents 1.7783% of the company's total share capital. The highest repurchase price was 52.99 yuan/share, the lowest price was 32.36 yuan/share, and the total amount of the repurchase transaction was 70.4314 million yuan (excluding transaction costs).
Related Articles
Strong demand for AI optical communication becomes the growth engine! Lumentum (LITE.US) Q4 performance and Q1 guidance both exceeded expectations.
Hong Kong Stock Concept Tracking | Major Release from Shanghai! Concerning AI Computing Power, These Subfields are Under Attention (With Related Stocks)
Hong Kong Stock Concept Tracking | Humanoid Siasun Robot & Automation Industry Accelerates towards "Mass Delivery" and is Expected to Become an Important Growth Pole in the Next Phase of AI (With Concept Stocks)
Strong demand for AI optical communication becomes the growth engine! Lumentum (LITE.US) Q4 performance and Q1 guidance both exceeded expectations.
Hong Kong Stock Concept Tracking | Major Release from Shanghai! Concerning AI Computing Power, These Subfields are Under Attention (With Related Stocks)
Hong Kong Stock Concept Tracking | Humanoid Siasun Robot & Automation Industry Accelerates towards "Mass Delivery" and is Expected to Become an Important Growth Pole in the Next Phase of AI (With Concept Stocks)
RECOMMEND
